glp-1 agonists with cardiovascular benefit The effects of receptor beyond obesity and type 2 diabetes: An anti-atherosclerotic action Cardiovascular benefits of glucagon-like peptide-1

Interdigestive migrating contractions are co-regulated by ghrelin and motilin in conscious dogs

The most widely used GLP-1 RAs today and those currently attributed with the most clinical evidence in weight management include Liraglutide, Semaglutide, and Tirzepatide (as a dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide) [25]

This potential synergistic effect is particularly useful in studies that aim to understand the complex interactions of growth hormone secretagogues and their effects on various physiological parameters

This research firmly establishes oxidative stress as a shared mechanistic basis for these conditions and underscores the critical need for targeted antioxidant therapies to protect cellular infrastructure

A weighted blanket increases pre-sleep salivary concentrations of melatonin in young, healthy adults